Aquestive Therapeutics Inc (AQST)
3.285
-0.08
(-2.38%)
USD |
NASDAQ |
May 02, 16:00
3.285
0.00 (0.00%)
After-Hours: 16:37
Aquestive Therapeutics Max Drawdown (5Y): 96.68% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 96.68% |
| March 31, 2024 | 96.68% |
| February 29, 2024 | 96.68% |
| January 31, 2024 | 96.68% |
| December 31, 2023 | 96.68% |
| November 30, 2023 | 96.68% |
| October 31, 2023 | 96.68% |
| September 30, 2023 | 96.68% |
| August 31, 2023 | 96.68% |
| July 31, 2023 | 96.68% |
| June 30, 2023 | 96.68% |
| May 31, 2023 | 96.68% |
| April 30, 2023 | 96.68% |
| March 31, 2023 | 96.68% |
| February 28, 2023 | 96.68% |
| January 31, 2023 | 96.68% |
| December 31, 2022 | 96.68% |
| November 30, 2022 | 96.68% |
| October 31, 2022 | 96.68% |
| September 30, 2022 | 96.68% |
| August 31, 2022 | 96.68% |
| July 31, 2022 | 96.68% |
| June 30, 2022 | 96.63% |
| May 31, 2022 | 94.83% |
| April 30, 2022 | 92.67% |
| Date | Value |
|---|---|
| March 31, 2022 | 91.88% |
| February 28, 2022 | 91.88% |
| January 31, 2022 | 91.88% |
| December 31, 2021 | 91.88% |
| November 30, 2021 | 91.88% |
| October 31, 2021 | 91.88% |
| September 30, 2021 | 91.88% |
| August 31, 2021 | 91.88% |
| July 31, 2021 | 91.88% |
| June 30, 2021 | 91.88% |
| May 31, 2021 | 91.88% |
| April 30, 2021 | 91.88% |
| March 31, 2021 | 91.88% |
| February 28, 2021 | 91.88% |
| January 31, 2021 | 91.88% |
| December 31, 2020 | 91.88% |
| November 30, 2020 | 91.88% |
| October 31, 2020 | 91.88% |
| September 30, 2020 | 91.88% |
| August 31, 2020 | 91.88% |
| July 31, 2020 | 91.88% |
| June 30, 2020 | 91.88% |
| May 31, 2020 | 91.88% |
| April 30, 2020 | 91.88% |
| March 31, 2020 | 91.88% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
80.38%
Minimum
May 2019
96.68%
Maximum
Jul 2022
92.30%
Average
91.88%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Lifecore Biomedical Inc | 89.19% |
| Harrow Inc | 71.15% |
| Akebia Therapeutics Inc | 98.40% |
| 89bio Inc | -- |
| Geron Corp | 86.09% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -44.98 |
| Beta (5Y) | 2.949 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 120.5% |
| Historical Sharpe Ratio (5Y) | -0.1005 |
| Historical Sortino (5Y) | -0.2697 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.27% |